Corvus Pharmaceuticals, Inc. (CRVS)

17.85 +0.71 (+4.14%) USD  |  NASDAQ  |  Apr 22, 16:00
17.73 -0.12 (-0.67%) Pre-Market: 09:21
More

Corvus Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Nektar Therapeutics Upgrade
Jaguar Health, Inc. Upgrade